Dr. Janet Yi Man Lee, MD, MPH

Dr. Lee practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Lee's NPI, 1336439777, was assigned on April 19, 2011. Dr. Lee graduated from Feinberg School of Medicine in 2011. Dr. Lee holds California license 136509.

Dr. Lee's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Lee's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Lee to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 4 sites in all. Vendor and product names are available with a free account.

Pediatric endocrinology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 2080P0205X. Dr. Lee is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 2 states: California and Indiana.

Dmand AI lists menopause and osteoporosis among the conditions Dr. Lee treats.

CMS data shows 31 Medicare services from Dr. Lee across 1 procedure code in 2019. Medicare paid $5,477 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 17, with 48% women.

In 2024, Dr. Lee wrote 20 Medicare Part D claims. 95% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $65 in total drug cost. In 2018, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Lee, published from 2018 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Mice, Knockout and Transgender Persons. Dr. Lee has published most often in Transgend Health. Dr. Lee's most frequent co-authors are Stephen Martin Rosenthal, MD, Fatema Abdulhussein, MD and Hal Blumenfeld, MD.

Dmand AI links Dr. Lee to 1 clinical trial. Conditions studied include Exostoses, Multiple Hereditary and Osteochondroma.

CMS Open Payments shows 18 general payments to Dr. Lee from 5 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 67% of the total. Ultragenyx Pharmaceutical Inc. paid the most, $6,285.

Dr. Lee graduated from Feinberg School of Medicine in 2011. Dr. Lee is a member of ASBMR, ENDO, PES and WPATH.

Dr. Lee is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.